Figure 1 (Tofidence 01)
Tofidence Injection
Product Images NDC 78206-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tofidence (NDC 78206-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Tofidence 02)
Principal Display Panel (200 mg/10 mL Vial Carton)
This text describes a medication named Tocilizumab-bavi, which comes in a 20 mg/mL solution for intravenous infusion in single-dose vials. The solution contains tocilizumab-bavi, arginine, histidine, polysorbate 80, sucrose, and other components. The recommended dosage and storage instructions are provided. Manufacturing information indicates that it is produced by Biogen MA Inc. in the USA.*
Principal Display Panel (400 mg/20 mL Vial Carton)
This is a description of a medication called "Tofidence" (tocilizumab-bavi) in the form of an injection solution. Each 1 ml of solution contains 20 mg of the active ingredient tocilizumab-bavi. The medication also includes other ingredients such as L-histidine hydrochloride, mannitol, polysorbate 80, sucrose, and water for injection. The recommended dosage and storage instructions are provided. The medication is manufactured by Sogen't and is available in a single-dose vial. It is for intravenous infusion use and should be protected from light and not frozen. Patients are required to receive the enclosed Medication Guide.*
Principal Display Panel (80 mg/4 mL Vial Carton)
This is a description for an injectable medication called tocilizumab-bavi, intended for intravenous infusion after dilution. It comes in a single-dose vial and should be refrigerated between 3°C to 8°C. The solution includes tocilizumab and arginine hydrochloride, among other components. The recommended dosage should be followed as per prescribing information. It is important to note that each patient is required to receive the enclosed Medication Guide with this product. The medication is manufactured by Bogen MA Inc in Cambridge, MA, USA, with a license number provided. The origin country is China.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
